Key result
Surgical management of a 24-kg giant retroperitoneal liposarcoma involved complete tumor excision, left nephrectomy, iliac artery repair, colectomy, and lymph node dissection.
Why the study?
The management of retroperitoneal liposarcoma is challenging due to tumor size and proximity to vital organs, highlighting the complexities and planning required for giant presentations.
Case Report (n=1)
Highlights the surgical management complexities of a giant retroperitoneal liposarcoma requiring multidisciplinary collaboration and extensive resection.
Surgical management feasible for giant symptomatic RL; leaves open standardization of care for rare retroperitoneal sarcomas.
Sarcomas are diverse malignant tumors originating from soft tissues (STS) or bones, with STS being more prevalent. Liposarcoma is the most common type of STS, typically arising in the extremities and retroperitoneum. This case report discusses the management of a rare, giant retroperitoneal liposarcoma (RL) in a 47-year-old man presented with significant abdominal enlargement, post-pharyngeal discharge, and urinary dribbling. Medical history included an inguinal hernia and smoking. Diagnosis through imaging (sonography, CT, MRI) and biopsy confirmed a well-differentiated liposarcoma encasing the left kidney and compressing abdominal organs. The tumor measured 53 × 47 x 20 cm and weighed 24 kg. Surgical management included complete tumor excision, left nephrectomy, iliac artery repair, colectomy, and lymph node dissection. The management of RL is challenging due to its size and proximity to vital organs. Complete surgical resection is crucial for recurrence-free survival. Preoperative radiotherapy can aid in achieving negative margins by defining target volumes and reducing irradiation of adjacent tissues. Chemotherapy is reserved for high-grade tumors with metastatic potential. This report highlights the complexities of managing giant RL, underscoring the importance of thorough surgical planning, multidisciplinary collaboration, and assessing potential adjunct therapies to improve patient prognosis.
No takes yet. Share an insight, caveat, or question.
Eghlimi et al. (2024) conducted a case report in Retroperitoneal liposarcoma (n=1). Surgical management (complete tumor excision, left nephrectomy, iliac artery repair, colectomy, and lymph node dissection) was evaluated. Surgical management of a 24-kg giant retroperitoneal liposarcoma involved complete tumor excision, left nephrectomy, iliac artery repair, colectomy, and lymph node dissection.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: